SEC Form 4 · accession 0001209191-16-155282
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 9:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.15 | Dec 12, 2016 | A | 69,100 | A | — | Dec 11, 2026 | Common Stock | 69,100 | 69,100 | D |
Explanation of responses
- F1The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of December 12, 2016.